How to Ensure Availability of Medicines and to Avoid Global Shortages
June 24, 2026
23BC
Type: Breakout Session
Focus Area:
Emerging Opportunities in Global Markets
This session focuses on shifting from reactive to preventative strategies in managing medicine shortages. Speakers will highlight supply chain resilience, harmonized processes and systems, and innovative solutions, while exploring how global partners collaborate to ensure medicine availability despite evolving legislative and geopolitical change.
Subtopic
Value and Access Opportunities and Challenges in Global Markets
Moderator
.jpg)
MSSG Co-Chair; President Federal Institute for Drugs and Medical Devices
Federal Institute for Drugs and Medical Devices (BfArM, DE)
Speakers
Head of supply and availability of medicines and devices
European Medicines Agency (EMA)
Assistant Director, Pharmacist – Medicine Shortages // Section Pharmacovigilance Branch
Australian Government Department of Health, Disability and Ageing
CDR, United States Public Health Service (USPHS) // Senior Program Management Officer
U.S. Food and Drug Administration (FDA)
Manager - Drug Shortages Unit
Health Canada / Government of Canada Santé Canada / Gouvernement du Canada
Senior Vice President, Alliance Development and Philanthropy
American Cancer Society Cancer Action Network
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}